期刊
CURRENT MEDICINAL CHEMISTRY
卷 23, 期 15, 页码 1496-1512出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867323666160405112954
关键词
Cancer; receptor tyrosine kinases; Axl; drug resistance; invasion; inhibitors
资金
- Associazione Italiana per la Ricerca sul Cancro, Milan, Italy [AIRC IG 15333]
- Fondazione I. Monzino
Aberrant expression and activation of receptor tyrosine kinases (RTK) is a frequent feature of tumor cells that may underlie tumor aggressiveness. Among RTK, Axl, a member of the Tyro3-Axl-Mer family, represents a potential therapeutic target in different tumor types given its over-expression which leads to activation of oncogenic signaling promoting cell proliferation and survival, as well as migration and invasion. Axl can promote aggressiveness of various cell types through PI3K/Akt and/or MAPK/ERK, and its expression can be transcriptionally regulated by multiple factors. Deregulated Axl expression and activation have been shown to be implicated in reduced sensitivity of tumor cells to target-specific and conventional antitumor agents, but the precise mechanism underlying these phenomena are still poorly understood. Several small molecules acting as Axl inhibitors have been reported, and some of them are undergoing clinical investigation. In this review, we describe Axl biological functions, its expression in cancer and in drug-resistant tumor cells and the development of inhibitors tailored to this receptor tyrosine kinase.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据